Claudine Bruck insider trades
Open-market stock purchases and sales by Claudine Bruck, Director at Annovis Bio, Inc, from SEC Form 4 filings since Mar 15, 2018.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -81%.
Recent trades
No open-market trades in the last 12 months.